Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherBrief Communications

Preclinical Comparison of 111In-Labeled DTPA- or DOTA-Bombesin Analogs for Receptor-Targeted Scintigraphy and Radionuclide Therapy

Wouter A.P. Breeman, Marion de Jong, Jack L. Erion, Joseph E. Bugaj, Ananth Srinivasan, Bert F. Bernard, Dik J. Kwekkeboom, Theo J. Visser and Eric P. Krenning
Journal of Nuclear Medicine December 2002, 43 (12) 1650-1656;
Wouter A.P. Breeman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marion de Jong
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jack L. Erion
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph E. Bugaj
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ananth Srinivasan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bert F. Bernard
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dik J. Kwekkeboom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Theo J. Visser
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric P. Krenning
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 43 no. 12 1650-1656
PubMed 
12468515

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online December 1, 2002.

Copyright & Usage 
THE JOURNAL OF NUCLEAR MEDICINE

Author Information

  1. Wouter A.P. Breeman, PhD1,
  2. Marion de Jong, PhD1,
  3. Jack L. Erion, PhD2,
  4. Joseph E. Bugaj, PhD2,
  5. Ananth Srinivasan, PhD2,
  6. Bert F. Bernard, MSc1,
  7. Dik J. Kwekkeboom, PhD1,
  8. Theo J. Visser, PhD3 and
  9. Eric P. Krenning, PhD1,3
  1. 1Department of Nuclear Medicine, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands
  2. 2Mallinckrodt Medical, St. Louis, Missouri
  3. 3Department of Internal Medicine, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands
View Full Text

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: December 2002 to April 2025

AbstractFullPdf
Dec 20027112468
Jan 2003126939
Feb 200373617
Mar 200383622
Apr 20035268
May 200371812
Jun 200321811
Jul 20039215
Aug 20038154
Sep 200311186
Oct 200314186
Nov 200315143
Dec 20038176
Jan 200415234
Feb 200411164
Mar 2004152711
Apr 200414175
May 200420237
Jun 200428315
Jul 2004345722
Aug 200412589
Sep 200412347
Oct 200414324
Nov 200414247
Dec 20047151
Jan 200514205
Feb 2005214113
Mar 2005154311
Apr 20052206
May 20059337
Jun 20057506
Jul 200513223
Aug 20059168
Sep 20057215
Oct 200513184
Nov 200515105
Dec 200514155
Jan 2006754
Feb 200641213
Mar 2006849
Apr 2006733
May 2006757
Jun 2006211
Jul 20068913
Aug 200661010
Sep 200691615
Oct 200671411
Nov 20063127
Dec 200661312
Jan 200741313
Feb 200781211
Mar 20078218
Apr 2007132012
May 20074148
Jun 2007698
Jul 2007102015
Aug 20076169
Sep 20076156
Oct 20074168
Nov 2007638
Dec 2007335
Jan 20083103
Feb 200841711
Mar 200881310
Apr 200891813
May 200812187
Jun 20089198
Jul 20087128
Aug 200815249
Sep 20081245
Oct 200872012
Nov 20084107
Dec 2008157
Jan 2009387
Feb 200910156
Mar 20096167
Apr 2009497
May 20097188
Jun 20094145
Jul 20094296
Aug 200972711
Sep 200992311
Oct 2009151712
Nov 20091078
Dec 200931713
Jan 20108714
Feb 20106108
Mar 201081014
Apr 20104105
May 201082014
Jun 201010127
Jul 2010232
Aug 2010524
Sep 201091013
Oct 201091315
Nov 20101178
Dec 201013713
Jan 20119146
Feb 2011778
Mar 201110159
Apr 20117184
May 2011474
Jun 201130117
Jul 201112811
Aug 2011171212
Sep 20111546
Oct 2011111416
Nov 2011151517
Dec 201114414
Jan 2012111215
Feb 2012141017
Mar 201220412
Apr 2012201311
May 2012171410
Jun 2012332911
Jul 2012191616
Aug 2012192614
Sep 201225246
Oct 2012202522
Nov 2012411112
Dec 201220910
Jan 2013282010
Feb 2013211515
Mar 201319910
Apr 20131947
May 2013201316
Jun 20131567
Jul 20131058
Aug 20131571
Sep 2013733
Oct 20131453
Nov 20137114
Dec 20131453
Jan 20148107
Feb 20148610
Mar 201414255
Apr 20141487
May 2014787
Jun 20141445
Jul 20141463
Aug 20146104
Sep 20143053
Oct 20146510
Nov 20149723
Dec 20141119
Jan 201518210
Feb 2015778
Mar 20152036
Apr 20151083
May 2015623
Jun 2015863
Jul 20156129
Aug 20151223
Sep 20151516
Oct 20151003
Nov 2015827
Dec 20152090
Jan 20162675
Feb 2016658
Mar 201620127
Apr 201620318
May 201638516
Jun 2016856
Jul 20166715
Aug 20169811
Sep 201681012
Oct 201681020
Nov 20160107
Dec 2016362
Jan 201710116
Feb 2017796
Mar 2017179
Apr 2017462
May 20175105
Jun 2017653
Jul 2017373
Aug 2017493
Sep 2017696
Oct 201712104
Nov 2017665
Dec 20176147
Jan 2018325
Feb 2018273
Mar 20185112
Apr 2018171
May 20181036
Jun 2018634
Jul 20180531
Aug 2018851
Sep 2018062
Oct 201851211
Nov 2018287
Dec 2018263
Jan 20191125
Feb 201931810
Mar 201942713
Apr 201991511
May 2019246
Jun 20197112
Jul 201961215
Aug 2019356
Sep 2019305
Oct 20191211
Nov 20196317
Dec 20193216
Jan 20205410
Feb 20201811
Mar 20204111
Apr 20207313
May 20209211
Jun 2020249
Jul 2020335
Aug 2020519
Sep 20204511
Oct 20206815
Nov 20203514
Dec 20202810
Jan 20212614
Feb 202131418
Mar 202181515
Apr 20212310
May 202151221
Jun 20212106
Jul 2021495
Aug 20215812
Sep 202111012
Oct 20210109
Nov 202162012
Dec 20212109
Jan 202271111
Feb 2022389
Mar 20228107
Apr 2022164
May 20227210
Jun 20225516
Jul 2022147
Aug 2022126
Sep 2022392
Oct 2022293
Nov 2022156
Dec 2022795
Jan 20238173
Feb 20231151
Mar 20232209
Apr 20232149
May 2023196
Jun 2023185
Jul 2023095
Aug 202321517
Sep 20232910
Oct 2023091
Nov 20237195
Dec 20232335
Jan 20242131
Feb 20241213
Mar 2024194
Apr 20246231
May 20242265
Jun 20244306
Jul 202442612
Aug 202494515
Sep 20245282
Oct 20249135
Nov 20241156
Dec 202411611
Jan 20251256
Feb 20252814
Mar 202535011
Apr 202502121
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 43, Issue 12
December 1, 2002
  • Table of Contents
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Preclinical Comparison of 111In-Labeled DTPA- or DOTA-Bombesin Analogs for Receptor-Targeted Scintigraphy and Radionuclide Therapy
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Preclinical Comparison of 111In-Labeled DTPA- or DOTA-Bombesin Analogs for Receptor-Targeted Scintigraphy and Radionuclide Therapy
Wouter A.P. Breeman, Marion de Jong, Jack L. Erion, Joseph E. Bugaj, Ananth Srinivasan, Bert F. Bernard, Dik J. Kwekkeboom, Theo J. Visser, Eric P. Krenning
Journal of Nuclear Medicine Dec 2002, 43 (12) 1650-1656;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Preclinical Comparison of 111In-Labeled DTPA- or DOTA-Bombesin Analogs for Receptor-Targeted Scintigraphy and Radionuclide Therapy
Wouter A.P. Breeman, Marion de Jong, Jack L. Erion, Joseph E. Bugaj, Ananth Srinivasan, Bert F. Bernard, Dik J. Kwekkeboom, Theo J. Visser, Eric P. Krenning
Journal of Nuclear Medicine Dec 2002, 43 (12) 1650-1656;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Preparation and In Vitro and In Vivo Characterization of the Tumor-specific Antigen-derived Peptide as a Potential Candidate for Targeting Human Epidermal Growth Factor Receptor 2-positive Breast Carcinomas
  • Targeted Radiotherapy of Prostate Cancer with a Gastrin-Releasing Peptide Receptor Antagonist Is Effective as Monotherapy and in Combination with Rapamycin
  • In Vitro and In Vivo Evaluation of 64Cu-Labeled SarAr-Bombesin Analogs in Gastrin-Releasing Peptide Receptor-Expressing Prostate Cancer
  • Design, Synthesis, Radiolabeling and In Vitro and In Vivo Characterization of Tumor-antigen- and Antibody-derived Peptides for the Detection of Breast Cancer
  • International Union of Pharmacology. LXVIII. Mammalian Bombesin Receptors: Nomenclature, Distribution, Pharmacology, Signaling, and Functions in Normal and Disease States
  • 177Lu-AMBA: Synthesis and Characterization of a Selective 177Lu-Labeled GRP-R Agonist for Systemic Radiotherapy of Prostate Cancer
  • 111In-Benzyl-DTPA-ZHER2:342, an Affibody-Based Conjugate for In Vivo Imaging of HER2 Expression in Malignant Tumors
  • Synergistic effects of light-emitting probes and peptides for targeting and monitoring integrin expression
  • GRP Receptor-Targeted PET of a Rat Pancreas Carcinoma Xenograft in Nude Mice with a 68Ga-Labeled Bombesin(6-14) Analog
  • 68Ga-Labeled Peptides in Tumor Imaging
  • Increased Cell Death After Therapy with an Arg-Gly-Asp-Linked Somatostatin Analog
  • Synthesis and Evaluation of Bombesin Derivatives on the Basis of Pan-Bombesin Peptides Labeled with Indium-111, Lutetium-177, and Yttrium-90 for Targeting Bombesin Receptor-Expressing Tumors
  • microPET and Autoradiographic Imaging of GRP Receptor Expression with 64Cu-DOTA-[Lys3]Bombesin in Human Prostate Adenocarcinoma Xenografts
  • Google Scholar

More in this TOC Section

  • Intraarterial Administration Boosts 177Lu-HA-DOTATATE Accumulation in Salvage Meningioma Patients
  • Head-to-Head Comparison of 68Ga-NOTA (68Ga-NGUL) and 68Ga-PSMA-11 in Patients with Metastatic Prostate Cancer: A Prospective Study
  • Assessment of P-Glycoprotein Transport Activity at the Human Blood–Retina Barrier with (R)‐11C-Verapamil PET
Show more Brief Communications

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire